GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
14.75
-0.15 (-1.01%)
Nov 26, 2025, 4:00 PM EST - Market closed
GH Research Market Cap
GH Research has a market cap or net worth of $914.93 million as of November 26, 2025. Its market cap has increased by 94.53% in one year.
Market Cap
914.93M
Enterprise Value
621.63M
1-Year Change
94.53%
Ranking
Category
Stock Price
$14.75
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $914.93M, an increase of 13.19%. That is a compound annual growth rate of 2.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 914.93M | 151.22% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |